학술논문

Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±).
Document Type
Article
Source
Stem Cell Reviews & Reports; Nov2023, Vol. 19 Issue 8, p2774-2789, 16p
Subject
INDUCED pluripotent stem cells
LONG QT syndrome
CRISPRS
GENETIC variation
DRUG discovery
SODIUM channels
Language
ISSN
15508943
Abstract
Copyright of Stem Cell Reviews & Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)